Oncotarget

Corrections:

Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma

PDF  |  How to cite

Oncotarget. 2019; 10:2236-2236. https://doi.org/10.18632/oncotarget.26807

Metrics: PDF 552 views  |   ?  

Roelants Caroline1,2, Giacosa Sofia1, Pillet Catherine3, Bussat Rémi1, Champelovier Pierre4, Bastien Olivier5, Guyon Laurent1, Arnoux Valentin4, Cochet Claude1 and Filhol Odile1

1 Université Grenoble-Alpes, Inserm U1036, CEA, BIG-BCI, Grenoble, France
2 Inovarion, Paris, France
3 Université Grenoble-Alpes, Inserm U1038, CEA, BIG-BGE, Grenoble, France
4 Centre Hospitalier Université Grenoble-Alpes, CS 10217, Grenoble, France
5 Université Grenoble-Alpes, CNRS-CEA-INRA, Laboratoire de Physiologie Cellulaire et Végétale, Grenoble, France

Published: March 15, 2019

This article has been corrected: The correct author information is given below:

Roelants Caroline1,2, Giacosa Sofia1, Pillet Catherine3, Bussat Rémi1, Champelovier Pierre4, Bastien Olivier5, Guyon Laurent1, Arnoux Valentin4, Cochet Claude1 and Filhol Odile1

Original article: Oncotarget. 2018; 9:30066-30078. DOI: https://doi.org/10.18632/oncotarget.25700.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26807